When Kate Youme decided to turn her own body hair into lab-grown diamonds, it was less a provocation than a test of how far ...
Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest ...
Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...
Morning Overview on MSN
'Fish mouth' filter removes 99% of microplastics from laundry
Microplastic fibers from synthetic clothing have quietly become one of the most pervasive forms of pollution in rivers, ...
After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...
Neuralink's Blindsight implant has received FDA breakthrough status, aiming to restore sight by stimulating the visual cortex ...
BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the ...
TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...
WASHINGTON, DC (ANI) – U.S. lawmakers and industry leaders are intensifying calls for stricter export controls to prevent American biopharmaceutical companies from collaborating with China military on ...
If you look at a stock chart mapping the performance of the State Street SPDR S&P Biotech exchange-traded fund since early 2021, it seems to tell a simple story: The biotech sector has been a disaster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback